NASDAQ:KOD

Kodiak Sciences Stock Signals

etoro logo Buy KOD
*Your capital is at risk
$19.83
+0.320 (+1.64%)
At Close: Nov 17, 2025

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 3.714 25 days ( -58.89 % )
Last Price $19.83 1.64 %
High/ Low $18.44 - $22.14 21.45%
Chg 7 Days 7.25 % $18.49 $19.83
Chg 30 Days 40.64 % $14.10 $19.83
Chg 12 mos 258.59 % $5.53 $19.83
Trend - 3 mos 107.42 % Width: 42.89 %
Trend - 12 mos 75.90 % Width: 198.09 %
Pred. range - 3 mos $33.84 - $48.36 70.67 % - 143.86 %
Pred. range - 12 mos $12.68 - $37.81 -36.03 % - 90.68 %
Short MA avg 3 mos Buy Nov 07, 2025 - 7 days
Long MA avg 3 mos Sell Oct 10, 2025 - 27 days
Short/Long MA avg 3 mos Sell Nov 30, -0001 - N/A days
Short MA avg 12 mos Sell Oct 16, 2025 - 23 days
Long MA avg 12 mos Buy Jun 30, 2025 - 99 days
Short/Long MA avg 12 mos Buy Jun 26, 2025 - 101 days
Pivot Short Sell Oct 30, 2025 - 13 days
Bollinger Buy Jul 09, 2025 - 93 days
MACD Sell No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!
ABOUT KODIAK SCIENCES INC.
Kodiak Sciences
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as well as for the treatment of diabetic macular edema, naïve macular edema due to retinal vein occlusion, ...
GOLDEN STAR
Ticker Change Signal Date
UNIT
$6.00
4.83% Nov 04
TBPH
$14.14
27.58% Oct 23
A
AMIX
$1.12
2.68% Oct 23
COCO
$40.85
11.21% Oct 23
LAUR
$29.55
1.20% Oct 22

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE